234 related articles for article (PubMed ID: 20069565)
1. LPA induces osteoblast differentiation through interplay of two receptors: LPA1 and LPA4.
Liu YB; Kharode Y; Bodine PV; Yaworsky PJ; Robinson JA; Billiard J
J Cell Biochem; 2010 Mar; 109(4):794-800. PubMed ID: 20069565
[TBL] [Abstract][Full Text] [Related]
2. Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass.
Gennero I; Laurencin-Dalicieux S; Conte-Auriol F; Briand-Mésange F; Laurencin D; Rue J; Beton N; Malet N; Mus M; Tokumura A; Bourin P; Vico L; Brunel G; Oreffo RO; Chun J; Salles JP
Bone; 2011 Sep; 49(3):395-403. PubMed ID: 21569876
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid (LPA) signaling via LPA
Takahashi K; Fukushima K; Onishi Y; Inui K; Node Y; Fukushima N; Honoki K; Tsujiuchi T
Biochem Biophys Res Commun; 2017 Jan; 483(1):652-657. PubMed ID: 27993681
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid induces vasodilation mediated by LPA1 receptors, phospholipase C, and endothelial nitric oxide synthase.
Ruisanchez É; Dancs P; Kerék M; Németh T; Faragó B; Balogh A; Patil R; Jennings BL; Liliom K; Malik KU; Smrcka AV; Tigyi G; Benyó Z
FASEB J; 2014 Feb; 28(2):880-90. PubMed ID: 24249637
[TBL] [Abstract][Full Text] [Related]
5. Non-Edg family LPA receptors: the cutting edge of LPA research.
Yanagida K; Ishii S
J Biochem; 2011 Sep; 150(3):223-32. PubMed ID: 21746769
[TBL] [Abstract][Full Text] [Related]
6. The lysophosphatidic acid receptor LPA4 regulates hematopoiesis-supporting activity of bone marrow stromal cells.
Igarashi H; Akahoshi N; Ohto-Nakanishi T; Yasuda D; Ishii S
Sci Rep; 2015 Jun; 5():11410. PubMed ID: 26090649
[TBL] [Abstract][Full Text] [Related]
7. LPA
Dancs PT; Ruisanchez É; Balogh A; Panta CR; Miklós Z; Nüsing RM; Aoki J; Chun J; Offermanns S; Tigyi G; Benyó Z
FASEB J; 2017 Apr; 31(4):1547-1555. PubMed ID: 28069828
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid-induced YAP/TAZ activation promotes developmental angiogenesis by repressing Notch ligand Dll4.
Yasuda D; Kobayashi D; Akahoshi N; Ohto-Nakanishi T; Yoshioka K; Takuwa Y; Mizuno S; Takahashi S; Ishii S
J Clin Invest; 2019 Jul; 129(10):4332-4349. PubMed ID: 31335323
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidic acid induces chemotaxis in MC3T3-E1 osteoblastic cells.
Masiello LM; Fotos JS; Galileo DS; Karin NJ
Bone; 2006 Jul; 39(1):72-82. PubMed ID: 16487757
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid enhanced the osteogenic and angiogenic capability of osteoblasts via LPA1/3 receptor.
Chen X; Song Z; Chen R; Tan S; Huang C; Liu Y; Cheng B; Fu Q
Connect Tissue Res; 2019 Mar; 60(2):85-94. PubMed ID: 29447019
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid-stimulated interleukin-6 and -8 synthesis through LPA1 receptors on human osteoblasts.
Aki Y; Kondo A; Nakamura H; Togari A
Arch Oral Biol; 2008 Mar; 53(3):207-13. PubMed ID: 17915188
[TBL] [Abstract][Full Text] [Related]
12. LPA signaling is required for dopaminergic neuron development and is reduced through low expression of the LPA1 receptor in a 6-OHDA lesion model of Parkinson's disease.
Yang XY; Zhao EY; Zhuang WX; Sun FX; Han HL; Han HR; Lin ZJ; Pan ZF; Qu MH; Zeng XW; Ding Y
Neurol Sci; 2015 Nov; 36(11):2027-33. PubMed ID: 26169757
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic Acid Receptor Agonism: Discovery of Potent Nonlipid Benzofuran Ethanolamine Structures.
Guillot E; Le Bail JC; Paul P; Fourgous V; Briand P; Partiseti M; Cornet B; Janiak P; Philippo C
J Pharmacol Exp Ther; 2020 Aug; 374(2):283-294. PubMed ID: 32409422
[TBL] [Abstract][Full Text] [Related]
14. Diverse effects of LPA4, LPA5 and LPA6 on the activation of tumor progression in pancreatic cancer cells.
Ishii S; Hirane M; Fukushima K; Tomimatsu A; Fukushima N; Tsujiuchi T
Biochem Biophys Res Commun; 2015 May; 461(1):59-64. PubMed ID: 25849892
[TBL] [Abstract][Full Text] [Related]
15. LPA1 receptor activation promotes renal interstitial fibrosis.
Pradère JP; Klein J; Grès S; Guigné C; Neau E; Valet P; Calise D; Chun J; Bascands JL; Saulnier-Blache JS; Schanstra JP
J Am Soc Nephrol; 2007 Dec; 18(12):3110-8. PubMed ID: 18003779
[TBL] [Abstract][Full Text] [Related]
16. Anatomical location of LPA1 activation and LPA phospholipid precursors in rodent and human brain.
González de San Román E; Manuel I; Giralt MT; Chun J; Estivill-Torrús G; Rodríguez de Fonseca F; Santín LJ; Ferrer I; Rodríguez-Puertas R
J Neurochem; 2015 Aug; 134(3):471-85. PubMed ID: 25857358
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid receptor 4 signaling potentially modulates malignant behavior in human head and neck squamous cell carcinoma cells.
Matayoshi S; Chiba S; Lin Y; Arakaki K; Matsumoto H; Nakanishi T; Suzuki M; Kato S
Int J Oncol; 2013 May; 42(5):1560-8. PubMed ID: 23467751
[TBL] [Abstract][Full Text] [Related]
18. Convergent regulation of neuronal differentiation and Erk and Akt kinases in human neural progenitor cells by lysophosphatidic acid, sphingosine 1-phosphate, and LIF: specific roles for the LPA1 receptor.
Callihan P; Ali MW; Salazar H; Quach N; Wu X; Stice SL; Hooks SB
ASN Neuro; 2014; 6(6):. PubMed ID: 25424429
[TBL] [Abstract][Full Text] [Related]
19. The LPA-LPA4 axis is required for establishment of bipolar morphology and radial migration of newborn cortical neurons.
Kurabayashi N; Tanaka A; Nguyen MD; Sanada K
Development; 2018 Sep; 145(17):. PubMed ID: 30217809
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between lysophosphatidic acid receptor 1 and tropomyosin receptor kinase A promotes lung epithelial cell migration.
Nan L; Wei J; Jacko AM; Culley MK; Zhao J; Natarajan V; Ma H; Zhao Y
Biochim Biophys Acta; 2016 Feb; 1863(2):229-35. PubMed ID: 26597701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]